Mepolizumab Reduces Need for Oral Steroids in Severe Asthma

(MedPage Today) -- PHOENIX -- Treatment with the interleukin-5 (IL-5) antagonist mepolizumab (Nucala) reduced the need to take oral corticosteroids by 75% in patients who had depended on the steroids to control symptoms of severe asthma, a researcher...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news